CD274 and neoplasm: At the tumor site, TAT modulated the tumor microenvironment (TME) with decreased protumoral alternatively activated macrophages and increased antitumoral macrophages and dendritic cells, as well as increased percentage of programmed death-ligand 1 (PD-L1)–positive (PD-L1pos) immune cells.